We have collected some facts & figures about last year’s EPP Life Sciences Pricing Forum 2016 in our Post Forum Report.

Read the closing remarks from our moderator on the 2016 edition of the Life Sciences Pricing forum, that took place in Montreux on September 20-21, 2016.

‘It was a privilege and a pleasure for me to moderate this year’s EPP Life Science forum, and my sincere thanks to EPP and their partners, to our first class presenters and to all our engaged and enthusiastic participants for making this 6th forum such a great success. This year’s theme ‘Pricing under Pressure’ obviously resonated very strongly with all who attended, and stimulated lots of high quality discussion, debate and ideas sharing among the participants from both pharma and MedTech. Read more.

 P1190219  P1190050  P1180617  P1180225
 P1180176  P1180607  P1180066  P1180572
 P1180226  P1180159  P1180175  P1180411
 P1180280  P1180038  Room  


7 reasons why you should attend the coming  EPP Life Sciences Pricing Forum in 2017

  1. Forum agenda topics fine-tuned with key industry  influencers. Meet the Life Sciences steering committee.
  2. Get an exclusive first look at new research and survey data
  3. Interactive workshops with pharma/generics and medtech/biotechnology tracks
  4. Discuss, learn and challenge both strategic and tactical topics
  5. Learn from reflection on your own business reality and discover creative solutions to your challenges
  6. Face-to-face conversations with top industry experts and your pricing peers during the innovative and interactive forum formats
  7. Learn how to eliminate risk and enhance revenue growth

Who should be attending?

Every year again 100+ attendees gather to discuss and reflect on the latest pricing and market access trends, learn about best business practices and meet world’s best experts in pricing and profit optimisation. The EPP Life Science s Pricing Forum brings together leading practitioners and experts to discuss, reflect, network and share. The forum is tailored for value, know-how and a unique opportunity for key stakeholdes such as CFO/commercial controller/Pricing and market access leads and VPs /Commercial /Sales Ops /Marketing/CIOs/commercial IT

More info contact els.landuyt@pricingplatform.eu or call +32(0)473.71.76.69.

This is an event you must attend!


    With more than 1000 minutes of network opportunity, you have plenty of time to connect with pricing colleagues from all over Europe.


    We stimulate an atmosphere of discussion and interaction, the best way to learn.


    A carefully selected speaking team of top pricing professionals, all active within your industry. No general talk, but only to-the point and useful presentations.


    Reflect on your key priorities and how to make it really happen !  Translate your key learnings into real change.


This is the speaker line-up of the 2016 edition of the EPP Life Sciences Pricing forum. If you would be interested to share your expertise or discuss with focus groups about your industry challenges for next year's edition, please send your contact details and session suggestions to els.landuyt@pricingplatform.eu.

Alan Crowther (USA)

CEO Alliance Life Sciences

About Alan

Alan Crowther, CEO for Alliance Life Sciences, is an industry recognized authority on global pricing and revenue management. With 20 years of consulting and technology experience in the Life Sciences industry, Alan’s leadership is focused on continually innovating to solve business challenges.



Dr. Michael Herepath (United Kingdom)

Managing Director Optimal Access Life Science Consulting Ltd.

About Michael

Because there’s no substitute for experience!

Michael is an experienced market access specialist offering a valuable set of capabilities gained from a career spanning market access and pricing strategy consultancy, global and UK affiliate-level pharma market access leadership roles, and as a senior payer in hospital pharmacy director and healthcare executive roles. With comprehensive knowledge and experience of market access dynamics, and of healthcare systems and bio-pharmaceutical policy affairs across the UK, Europe, the US, and the key emerging markets of Asia Pacific and Latin America, he has an excellent track record in working with cross-functional global, regional and affiliate teams to deliver optimal solutions through productive collaborations with external stakeholders, while providing leadership, direction, development and ongoing motivation to colleagues. Qualified as a clinical pharmacist, and with pharma, consultancy, payer and clinical pharmacy experience in all key therapy areas, he has worked with a large range of pharmaceutical and biotechnology companies, as well as the leading medical technology companies. Trained and experienced in the application of health economic evidence in market access, and also trained in social research methodology, is a specialist in the design, development and delivery of pharmaceutical market access and pricing strategies who is able to apply valued knowledge, skills, experiences, contacts and network


Ruven Eul (Germany)

Manager of the European Life Sciences Highpoint Solutions

About Ruven

Ruven is a Manager of the European Life Sciences at HighPoint Solutions based out of Zug, Switzerland. Ruven has worked for around 8 years in Germany for much of his career at companies such as Pfizer and BMS in local, regional and global roles. Ruven comes from a deep background in the areas of Commercial Excellence with strong domain experience in CRM, Commercial Analytics, and Tendering working with industry leading products such as Veeva. Ruven has been involved in rollouts of Veeva as a Deployment Lead for multiple countries and as a Subject Matter Expert for Tender Management projects within Europe.



Julie Spiesser (France)

Associate Vice President Global Strategic Pricing Sanofi

About Julie

Julie Spiesser is a Health Economist specialized in Market Access and Pricing. She has been working for the Pharma industry since 15 years. She started her carreer at Sanofi R&D working in Psychiatry and Cardiovascular area. She joined the Sanofi European team as Senior Market access Manager and took later on the position of European Outcomes Research Director at Pfizer for anti-infective Disease Area. And since 2010 she is heading the Global Strategic Pricing team of Sanofi.

Tsveta Milanova (USA)

VP Corporate Pricing & Market Access Celgene

About Tsveta

Tsveta Milanova works at Celgene EMEA for six years now, most recently as VP Corporate, Pricing and Market Access. She has led numerous workshops with leading industry experts and also developed market access strategies for pre-launch products and new indications.

Photo Daniel Cho

Daniel Cho (Germany)

Director Marketing, Global Pricing & Competitive Portfolio Analytics - Patient Care and Monitoring Solutions Philips Healthcare

About Daniel

Daniel Cho is currently the Director of Global Pricing for Patient Care and Monitoring Systems, a 3B Euro Business Group under Philips Healthcare. He heads a team of Pricing Managers to use Pricing as a tool to maximise the profitability of PCMS by better manage the Creation, Capturing and Maintenance of the values PCMS can deliver to their end customers.

Sara Aswegan (Switzerland)

Senior Vice President Ultragenyx Pharmaceuticals Inc.

About Sara

Sara has recently joined Ultragenyx Pharmacuetical Inc. as Senior Vice-President. Before that she led the Product Strategy Teams for the MPS II Business in the Rare Disease Business Unit, supporting the second largest revenue contributor for Shire with ELAPRASE, as well as plans for commercial success with the development products for Hunter CNS.

Adam Plich (The Netherlands)

VP, Head of Pricing & Market Access Europe TEVA Pharmaceutical Europe

About Adam

Adam has been working with Teva since 2012 as Head of Pricing and Market Access, first based in London now in Amsterdam.  Teva Pharmaceutical is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products.

Finn Ziegler (Denmark)

Director, Global Patient Access LEO Pharma

About Finn

Finn has recently joined LEO Pharma, after having worked for 6 years as International Contracts and Pricing Manager with Amgen, responsable for pricing and contract strategy and implementation.

His specialties lie in the domain of pricing research & strategies, health economics, public procurement and reimbursement of pharmaceuticals, public policy & affairs, think tanks, parallel trade and reference pricing in the pharmaceutical industry

Bertrand Tardivel (Switzerland)

Head of Global Pricing Takeda Pharmaceuticals International

About Bertrand

Bertrand joined Takeda in August 2013 as Head of Global Pricing. Moving from controller to consultant and business development manager for different companies, he has built a broad experience in the pharmaceutical sector. With Takeda he joined a company that for more than 230 years has been serving society with innovative medicines, helping patients reclaim valuable moments of life from illness.

Gustavo Saraiva (UK)

Head of Pricing and Access Intelligence Otsuka Pharmaceuticals Europe

About Gustavo

Gustavo is the head of the Pricing and Access Intelligence at Otsuka Pharmaceuticals Europe, where he is in charge of developing the pricing strategies for the entire product portfolio as well as providing business intelligence insights to the global organisation. His previous years indicate his wealth and expertise in the finance industry before transitioning into Pricing and Market Access. Prior to joining Otsuka he worked with LEO Pharma for three years as a Global Pricing Manager where he had to manage both strategic and operational pricing at a global and local level. Gustavo graduated in Business administration and has a Masters degree in Finance from NOVA School of Business and Economics in Lisbon – Portugal. He also holds an MBA from Universidade Federal Fluminense in Rio de Janeiro – Brazil.

Alan Crowther (USA)

CEO Alliance Life Sciences

About Alan

Alan Crowther, CEO for Alliance Life Sciences, is an industry recognized authority on global pricing and revenue management. With 20 years of consulting and technology experience in the Life Sciences industry, Alan’s leadership is focused on continually innovating to solve business challenges.


Richard Fergusson (Switzerland)

EMEA Director of Strategic Pricing BD

About Richard

Richard has 15 years of experience in the Medical Technology industry, in various sales, marketing and strategy roles, with the majority of this time closely connected to the topic of Strategic Pricing. Richard is currently the EMEA Director of Strategic Pricing for Becton Dickinson, a global manufacturer of diagnostic and drug delivery devices. During his 4 years at the company he has led a program to build and shape strategic pricing capabilities across the region, as well as taking responsibility for building the regional Health Economics function and for various global pricing programs focused on implementation and adoption of pricing related systems and harmonised processes. Richard started his career as a medicinal chemist, spent a number of years as a management consultant with Andersen prior to completing his MBA at Leeds University Business School, during which time he worked closely with academics and local business incubators to research the topic of technology transfer. He has recently returned to academia to study part time for a Masters in International HTA and healthcare reimbursement at the University of Sheffield.



“A conference really dedicated to Pricing”

Clotilde Noble, at Ferring Pharmaceuticals

Excellent conference with very interesting topics and excellent speakers. I attempted this conference two times and I would like to participate to the next one.

‘I enjoyed the opportunity to meet, listen to and network with pricing professionals.’

Raj Kanapathy, at Siemens Healthcare

I enjoyed the opportunity to meet, listen to and network with pricing professionals in the Life Science industry and would definitely recommend the experience to other pricing professionals.

“It’s much more lively and interactive!”

Madalina Preda, European Pricing Supervisor at Corning BV

It is much more lively and focussed on burning issues in the Life Science markets.

Meet pricing decision makers from:





- If you are a belgian based company (VAT required), please contact els.landuyt@pricingplatform.eu to complete your registration.
- Click on the 'Show other payment options' to pay by bank transfer.
- EPP Members benefit from our preferred membership rates? Check out the conditions for membership at http://www.pricingplatform.eu/participate/becomeaparticipant/corporate-membership.html
- Once a registration is completed, tickets are transferable but never refundable. This applies to payments via invoice as well.